Disease-specific quality-of-life measurement tools for haemophilia patients

Haemophilia, Supplement

Volumn 10, Issue 4, 2004, Pages 30-34

  Remor, Eduardo ^a   Young, N L ^b   Von Mackensen, S ^c   Lopatina, E G ^d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Adults; Assessment; Children; Haemophilia; Quality of life

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CULTURAL ANTHROPOLOGY; HEMOPHILIA; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; PSYCHOMETRY; PUBLICATION; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 11044219929     PISSN: 13550691     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2004.01004.x     Document Type: Article

References (28)

1. Bullinger M. Quality of life-definition, conceptualization and implications a methodologist's view. Theor Surg 1991; 6: 143-9.
2. Beeton K. Evaluation of outcome of care in patients with haemophilia. Haemophilia 2002; 8: 428-34.
3. Fischer K, van der Bom JG, van der Berg HM. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia 2003; 9 (Suppl. 1): 75-82.
4. Bullinger M, von Mackensen S. Quality of life assessment in haemophilia. Haemophilia 2004; 10 (Suppl. 1): 9-16.
5. Rosendaal FR, Smit C, Varekamp I et al. Modern haemophilia treatment. medical improvement and quality of life. J Intern Med 1990; 228: 633-40.
6. Szucs TD, Offner A, Schramm W. Socioeconomic impact of haemophilia care: results of a pilot study. Haemophilia 1996; 2 211-7.
7. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Ebrahim S, Lee CA. Assessing health-related quality-of-life in patients with severe haemophilia A and B. Psych Health Med 1999; 4: 5-15.
8. Miners AH, Sabin CA, Tolley KH et al. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999; 5: 378-85.
9. Aznar JA, Magallón M, Querol F, Gorina E, Tusell JM. The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 2000; 6: 170-6.
10. Brewin T, Ekert H, Davey P. Recombinant VIIA (NovoSeven) treatment of six children with long-standing inhibitors improves quality of life. Haemophilia 2000; 6: 414.
11. Khair K. Quality of life in children with haemophilia. Haemophilia 2000; 6: 419.
12. Sek J, Saleh M, Furlong W, et al. Health-related quality of life in people living with haemophilia or von Willebrand disease in a geographical population. Haemophilia 2000; 6: 426-7.
13. Molho P, Rolland N, Lebrun T et al. Epidemiological survey of the orthopedic status of severe haemophilia A and B patients in France. Haemophilia 2000; 6: 23-32.
14. Schick M, Stucki G, Rodriguez M et al. Haemophilic arthropathy: assessment of quality of life after total knee arthroplasty. Clin Rheumatol 1999; 18: 468-72.
15. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001; 7: 53-63.
16. Ekert H, Brewin T, Boey W, Davey P, Tilden D. Cost-utility analysis of recombinant factor VIIa (NovoSeven) in six children with long-standing inhibitors to factor VIII or IX. Haemophilia 2001; 7: 279-85.
17. Trippoli S, Vaiani M, Linari S, Longo G, Morfini M, Messori A. Multivariate analysis of factors influencing quality-of-life and utility in patients with haemophilia. Haematologica 2001; 86: 722-8.
18. Schoenmakers MA, Gulmans VA, Helders PJ, van den Berg HM. Motor performance and disability in Dutch children with haemophilia: a comparison with their healthy peers. Haemophilia 2001; 7: 293-8.
19. Royal S, Schramm W, Berntorp E et al., for the European Haemophilia Economics Study Group. Quality-of-life differences between prophylactic end on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002; 8: 44-50.
20. Gringeri A, Mantovani L, Scalone L, Mannuchi P for the COCIS Study Group. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003; 102: 2358-63.
21. Bullinger M, von Mackensen S, Fisher K et al. Pilot testing of the 'Haemo-QoL' quality of life questionnaire for haemophiliac children in six European countries. Haemophilia 2002; 8 (Suppl. 2): 47-54.
22. von Mackensen S, Bullinger M and the Haemo-QoL Group. Development and testing of an instrument to assess the quality of life of children with haemophilia in Europe (Haemo-QoL). Haemophilia 2004; 10 (Suppl. 1): 17-25.
23. Arranz P, Remor E, Quintana M et al. Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia 2004; 10: 1-7.
24. Young NL, Bradley CS, Blanchette V, et al. Development of a health related quality of life measure for boys with haemophilia: the Canadian Hemophilia Outcomes - Kids Life Assessment Tool (CHO-KLAT). Haemophilia 2004; 10 (Suppl. 1): 34-43.
25. Remor E. and the Hemolatin-QoL Group. Hemolatin-QoL: Desarrollo de una medida específica para la evaluación de la calidad de vida en pacientes adultos con hemofilia en America-Latina. Terapia Psicología 2004; 22: in press.
26. Bullinger MV, Mackensen S, the Haemo-QoL Group. Quality of life in children and families with bleeding disorders. J Pediatric Haematol Oncol 2003; 25: 64-7.
27. Gringeri Av, Mackensen S, Auerswald G, et al., for the Haemo-QoL Study. Health status and health-related quality of life of children with haemophilia from six west European countries. Haemophilia 2004; 10 (Suppl. 1): 26-33.
28. Barnard D, Woloski M, Feeny D, et al. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatric Hematol Oncol 2003; 25: 56-62.